Terry P. Gould serves as Executive at OncoMed Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, Terry P. Gould has executed 106 insider transactions totaling $12.4M, demonstrating a bullish approach to their equity position. Their most recent transaction on May 9, 2014 involved transacting 1,017 shares valued at $0.
Terry P. Gould currently holds 996,169 shares of OncoMed Pharmaceuticals Inc (OMED), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Terry P. Gould has been a net buyer of OMED stock. They have purchased $12.4M and sold $0 worth of shares.
Terry P. Gould's most recent insider trade was on May 9, 2014, when they sold 1,017 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 23, 2013 | OMED | $0 | Conversion | 322,142 | $N/A | Discretionary |
| Jul 23, 2013 | OMED | $0 | Conversion | 270,811 | $N/A | Discretionary |
| Jul 23, 2013 | OMED | $0 | Conversion | 348,652 | $N/A | Discretionary |
| Jul 23, 2013 | OMED | $0 | Conversion | 293,098 | $N/A | Discretionary |